Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital

scientific article published in March 2010

Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/13693780903161216
10.3109/13693780903161216
P698PubMed publication ID19657956

P50authorCintia AlvesQ33047219
Paula SampaioQ40685935
Célia PaisQ40686042
Raquel SabinoQ41183613
Cristina VeríssimoQ41443394
João BrandãoQ42214555
P2093author name stringC. Pais
C. Verissimo
E Paixão
E. Paixao
H Parada
H. Parada
J. Brandao
L Rosado
L. Rosado
R. Sabino
T Tendeiro
T. Tendeiro
Z Videira
Z. Videira
P2860cites workEpidemiology of invasive candidiasis: a persistent public health problemQ29616758
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazoleQ33273842
A first Portuguese epidemiological survey of fungaemia in a university hospitalQ33378325
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Q33753405
Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, CanadaQ33971521
The impact of hospital-acquired bloodstream infectionsQ34213597
Candidaemia and cancer: patients are not all the sameQ34521837
Acquired resistance to echinocandins in Candida albicans: case report and reviewQ34623936
Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic reviewQ34656117
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.Q34680777
Candidaemia in Europe: epidemiology and resistanceQ36463475
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.Q36497888
Nosocomial fungal infections: epidemiology, diagnosis, and treatmentQ36825717
The importance of central venous catheter removal in patients with candidaemia: time to rethink our practice?Q37001614
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance programQ37420953
Study of molecular epidemiology of candidiasis in portugal by PCR fingerprinting of Candida clinical isolatesQ37702847
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospitalQ38899448
Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unitQ39628031
Candidemia in acute leukemia patientsQ40651507
Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.Q41484209
Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patientsQ43664009
Management of central venous catheters in patients with cancer and candidemiaQ43877465
Risk factors for breakthrough candidemiaQ43961912
The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm productionQ43976981
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United StatesQ44417864
In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.Q45200724
Invasive candidiasis in cancer patients: observations from a randomized clinical trialQ46501606
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.Q50700185
A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia.Q51188642
P433issue2
P921main subjectepidemiologyQ133805
candidemiaQ54946225
P304page(s)1-10
346-354
P577publication date2009-01-01
2010-03-01
P1433published inMedical MycologyQ6806389
P1476titleEpidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital
P478volume48

Reverse relations

cites work (P2860)
Q42713801A novel antifungal agent with broad spectrum: 1-(4-biphenylyl)-3-(1H-imidazol-1-yl)-1-propanone.
Q59282466Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity
Q37794979Candida tropicalis in human disease
Q41987503Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
Q33717144Epidemiology and prognostic factors of candidemia in cancer patients
Q41726019Epidemiology and prognostic factors of candidemia in elderly patients
Q45850889Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil.
Q36414000In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study
Q60923177Increase in Candida parapsilosis candidemia in cancer patients
Q44418924Increase in Candida parapsilosis fungemia in critical care units: a 6-years study
Q33985357Isolates from hospital environments are the most virulent of the Candida parapsilosis complex
Q40344147New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto isolates
Q92188791Relevance of Macrophage Extracellular Traps in C. albicans Killing
Q37742252The risk and clinical outcome of candidemia depending on underlying malignancy

Search more.